Compare Ginkgo Bioworks Holdings Inc (DNA) vs KLA Corp. (KLAC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ginkgo Bioworks Holdings Inc vs KLA Corp. — how do they compare? Ginkgo Bioworks Holdings Inc trades at $9.05 (market cap $591.19M), while KLA Corp. trades at $238.75 (market cap $290.32B). The key difference: KLA Corp. is far larger — about 491.1× Ginkgo Bioworks Holdings Inc's market cap, and KLA Corp. pays a 0.41% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals.
| DNA | KLAC | |
|---|---|---|
Market Cap | $591.19M | $290.32B |
Sector | Health | Technology |
52-Week High | $16.14 | $301.71 |
52-Week Low | $5.48 | $84.39 |
Enterprise Value | $628.43M | $291.51B |
Dividend Yield | — | 0.41% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →About KLA Corp.
KLA designs and manufactures yield-management and process-monitoring diagnostic and control systems for the semiconductor manufacturing industry. The systems are used to analyze the manufacturing process at various steps in a semiconductor's development. The firm's laser-scanning products are used for wafer qualification, process monitoring, and equipment monitoring. KLA also provides inspection tools and systems for optical metrology and e-beam metrology.
Read more on KLAC →
